Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Link to SEPIO compliant JSON-LD document

Variant: NM_001386306.1:c.1095C>G

CA343772391

Gene: SERPINC1

Condition: antithrombin III deficiency

Inheritance Mode: Autosomal dominant inheritance

Link to MONDO

UUID: e969f093-b6e9-4944-8519-e89b0379626f

Approved on: 2024-02-19

Published on: 2024-02-19

HGVS expressions

NM_001386306.1:c.1095C>G

NC_000001.11:g.173903973G>C

CM000663.2:g.173903973G>C

NC_000001.10:g.173873111G>C

CM000663.1:g.173873111G>C

NC_000001.9:g.172139734G>C

NG_012462.1:g.18406C>G

ENST00000367698.4:c.1311C>G

ENST00000367698.3:c.1311C>G

ENST00000617423.4:c.696C>G

NM_000488.3:c.1311C>G

NM_001365052.1:c.1167C>G

NM_000488.4:c.1311C>G

NM_001365052.2:c.1167C>G

NM_001386302.1:c.1434C>G

NM_001386303.1:c.1392C>G

NM_001386304.1:c.1290C>G

NM_001386305.1:c.1254C>G

Pathogenic

PP3 PP1_Strong PS4

BS1 PM2

Evidence Links 0

Expert Panel

Thrombosis VCEP

Criteria Specification Information

Criteria Specifications for this VCEP

Evidence submitted by expert panel

Thrombosis VCEP

The c.1311C>G (NM_000488.3) variant in SERPINC1 is a missense variant predicted to cause substitution of asparagine by lysine at amino acid 437 (p.Asn437Lys). The computational predictor REVEL gives a score of 0.683, which is above the threshold of >0.6 and provides evidence that correlates with impact to SERPINC1 function, meeting criteria for PP3. The variant has been reported in at least 8 probands with AT deficiency in the literature (7.5 points applied PMID 28300866; PMID 24684277; PMID 12755798; PMID 1469094). The variant has been reported to segregate with autosomal dominant hereditary antithrombin deficiency in 7 affected family meioses from 4 families (PP1_strong; PMID: 1469094; PMID: 12755798; PMID: 28300866). In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Thrombosis Variant Curation Expert Panel for SERPINC1: PP1_Strong, PS4, PP3.

PP3

The computational predictor REVEL gives a score of 0.683, which is above the threshold of >0.6 and provides evidence that correlates with impact to SERPINC1 function, meeting criteria for PP3.

PP1_Strong

The variant has been reported to segregate with autosomal dominant hereditary antithrombin deficiency in 7 affected family meioses from 4 families (PP1_supporting; PMID: 1469094; PMID: 12755798; PMID: 28300866).

PS4

The variant has been reported in at least 8 probands with AT deficiency in the literature (7.5 points applied PMID 28300866; PMID 24684277; PMID 12755798; PMID 1469094).

BS1

The variant is reported at the highest MAF of 0.00005437 (1/18392 alleles) in the East Asian population in gnomAD v2.1.1, which does not meet criteria for BS1 (MAF >=0.0002).

PM2

The variant is reported at the highest MAF of 0.00005437 (1/18392 alleles) in the East Asian population in gnomAD v2.1.1, which does not meet criteria for PM2_Supporting (MAF =< 2.0 X 10-5 in gnomAD).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.